Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie 02. Februar 2026
Suchen
Gastroplattform
Neoplasie
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Leber
Magen-Darm
Oesophagus
Pankreas
Neoplasie
Pankreatitis
Anderes
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 2946  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 58920  
   
Paraneoplastic dermatomyositis with atypical features associated with a solid pseudopapillary pancreatic neoplasm.
Clin Rheumatol
Uribe-Ruíz NA, Domínguez-Guzmán DA, Jaramillo-Álvarez JC, Vargas-Camacho AF, Pineda C, Restrepo-Escobar M, Muñoz-Vahos CH, González-Naranjo LA, Vanegas-García AL.
PMID: 41620566 [PubMed - as supplied by publisher]


Implications of Homologous Recombination Deficiency for Neoadjuvant Platinum-Based Chemotherapy in Pancreatic Cancer: A Narrative Review.
Ann Surg Oncol
Liguori L, Ventin M, Cattaneo G, Zhang L, Osipov A, Sabbatino F, Ferrone CR.
PMID: 41620555 [PubMed - as supplied by publisher]


Sequential platinum and PARP Inhibition enhances PD1 immunotherapy efficacy in murine Brca2 mutated pancreatic cancer.
Sci Rep
McVey JC, Wattenberg MM, Coho H, Infante K, Markowitz K, Delman D, Clendenin C, Furth EE, Tondon R, Stanger BZ, Vonderheide RH, Reiss KA, Beatty GL.
PMID: 41620448 [PubMed - as supplied by publisher]


Prospective study of anamorelin in pancreatic cancer cachexia: Clinical and translational insights into response heterogeneity.
Clin Nutr
Matsukane R, Minami H, Fujimori N, Ueda K, Komori Y, Takamatsu Y, Ueda T, Kimura M, Matsuzaki C, Tanaka T, Morito A, Kuwahara S, Hashimoto M, Hirai S, Yokoyama T, Ishida S, Hirota T, Ogawa Y, Uchida M.
PMID: 41619712 [PubMed - as supplied by publisher]


Modulation of Network Plasticity Opens Novel Therapeutic Possibilities in Cancer, Diabetes, and Neurodegeneration.
Adv Sci (Weinh)
Kerestély M, Narozsny I, Szarka L, Veres DV, Csermely P, Keresztes D.
PMID: 41618842 [PubMed - as supplied by publisher]


Multimodal Prehabilitation In Pancreatic cancer Patients undergoing surgery (PIPS): study protocol for a randomized controlled trial.
Trials
Pecorelli N, Fermi F, Abati M, Bonomi B, Fossati L, Corti G, Guarneri G, Macchini M, Damascelli A, Palumbo D, Gaviraghi S, Di Mattei V, De Cobelli F, Tettamanti A, Falconi M.
PMID: 41618415 [PubMed - as supplied by publisher]


Evaluation of efficacy of a polyglycolic acid sheet in laparoscopic gastrectomy for gastric cancer: a single-center retrospective study.
BMC Gastroenterol
Yanagawa S, Yamamoto Y, Nakagawa T, Yamaguchi M, Shiozaki S, Tanabe K, Nakahara M, Noriyuki T.
PMID: 41618166 [PubMed - as supplied by publisher]


Early Predictive Factors for Severe Postoperative Complications Following Major Liver and Pancreatic Surgery.
Anticancer Res
Fukada M, Mitsui N, Horaguchi T, Yasufuku I, Sato Y, Tajima JY, Tanaka Y, Matsuhashi N.
PMID: 41617460 [PubMed - indexed for MEDLINE]


Prognostic Factors and the Impact of Adjuvant S-1 Chemotherapy in Resected Ampulla of Vater Carcinoma: A Single-institution Retrospective Study.
Anticancer Res
Imamura H, Adachi T, Hamada T, Migita K, Satoh A, Kurotaki K, Nakamura S, Ogawa S, Askeyev B, Matsushima H, Kinoshita A, Soyama A, Eguchi S.
PMID: 41617443 [PubMed - indexed for MEDLINE]


Prognostic Significance of Extrapancreatic Invasion in Pancreatic Cancer: Excellent Outcomes in Patients With Disease Confined Within the Pancreas.
Anticancer Res
Saito R, Amemiya H, Izumo W, Oka T, Maruyama S, Takiguchi K, Shoda K, Shiraishi K, Furuya S, Kawaguchi Y, Kawaida H, Ichikawa D.
PMID: 41617417 [PubMed - indexed for MEDLINE]


Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma.
J Immunother Cancer
O'Reilly EM, Cabanski CR, Lyman JP, Wainberg ZA, Fisher GA, Wolff RA, Ko AH, O'Hara MH, Spencer CN, Yu JX, Da Silva DM, Padrón LJ, Arnott J, Fairchild J, Moore JS, Peng B, Hoos WA, O'Donnell-Tormey J, Boffo S, Dugan U, Kimmelman AC, Amaravadi RK, Vonderheide RH.
PMID: 41617393 [PubMed - indexed for MEDLINE]


Renal Cell Carcinoma Metastasis to the Pancreas: A Comprehensive Review.
J Gastrointest Surg
Aziz H, Kotla A, Abbey R, Toliver BC, Gosse M, Yasmine N, Aswani Y, Pawlik T.
PMID: 41617051 [PubMed - as supplied by publisher]


Emerging landscape of KRAS inhibitors in cancer treatment.
Cancer Cell
Riedl JM, Matsubara H, McNeil R, Patel PS, Fece de la Cruz F, Gulhan DC, Corcoran RB.
PMID: 41616774 [PubMed - as supplied by publisher]


An interpretable machine learning model for predicting survival in pancreatic cancer via SHAP: a multicenter study.
J Gastroenterol
Ren H, Fei H, Niu P, Xu X, Wen Z, Sun C, Li Z, Li Z, Zhang H, Zhao D.
PMID: 41615460 [PubMed - as supplied by publisher]


Evaluation of Endoscopic Ultrasound Delays in the Diagnosis of Pancreatic Cancer in Older Adults in the United States.
Clin Transl Gastroenterol
Radwan RM, Huang W, Barney G, Fieber J, Guo J, Novikov A.
PMID: 41614718 [PubMed - as supplied by publisher]


Mechanistic insights into pancreatic cancer progression from circadian rhythm disruption and gut microbiota dysbiosis (Review).
Int J Mol Med
Liu Y, Li Y, Ma H, Deng S, Cheng C.
PMID: 41614406 [PubMed - indexed for MEDLINE]


Development of a Modified Textbook Outcome in Evaluating Robot-Assisted Middle Pancreatectomy: A Real-World Study of RMP Surgery in a High-Volume Pancreatic Disease Center.
Cancer Med
Li J, Qian L, Xu Z, Wang X, Xu W, Deng X, Peng C, Shen B, Shi Y.
PMID: 41614281 [PubMed - indexed for MEDLINE]


Comprehensive Cancer Networks in the Netherlands: how do they affect quality and costs of care for colon or pancreatic cancer? A retrospective cohort study.
BMJ Open
Vrinzen CEJ, Stadhouders N, Bloemendal HJ, Hayen A, Reitsma J, Ten Hove M, Jeurissen PPT, Merkx MAW, Hermens RPMG.
PMID: 41611455 [PubMed - indexed for MEDLINE]


Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial.
J Clin Oncol
Willems RAL, van Diepen AE, Dekker EN, Janssen QP, van Dam JL, Michiels N, van Eijck CWF, Hermans KEPE, Bonsing BA, Bosscha KP, Bouwense SAW, Busch OR, Ten Cate H, Coene PLO, van Eijck CHJ, van Es N, van der Harst E, de Hingh IHJT, Karsten TM, Kazemier G, van der Kolk MB, de Laat B, Liem MSL, Mieog JSD, Nieuwenhuijs VB, Patijn GA, Roest M, van Santvoort HC, Valkenburg-van Iersel L, de Wilde RF, Wit F, Zonderhuis BM, Besselink MG, Homs MYV, van Tienhoven G, Wilmink JW, Groot Koerkamp B, de Vos-Geelen J, Dutch Pancreatic Cancer Group.
PMID: 41610374 [PubMed - as supplied by publisher]


The usefulness of the serum fibrinogen-to-albumin ratio as a preoperative predictor of HGD or IC in intraductal papillary mucinous neoplasm of the pancreas.
Dig Surg
Ochiai S, Chiba N, Yamaguchi H, Suda R, Nagae Y, Seichi T, Nakagawa M, Gunji T, Kobayashi T, Sano T, Kikuchi Y, Tabuchi S, Ishizaki T, Kawachi S.
PMID: 41610059 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 58920    Seite 1 von 2946  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1